TNDM logo

TNDM
Tandem Diabetes Care Inc

13,957
Mkt Cap
$969.69M
Volume
1.51M
52W High
$29.65
52W Low
$9.98
PE Ratio
-10.10
TNDM Fundamentals
Price
$12.97
Prev Close
$14.15
Open
$13.63
50D MA
$20.21
Beta
1.30
Avg. Volume
1.56M
EPS (Annual)
-$3.04
P/B
7.32
Rev/Employee
$406,140.00
$1,635.63
Loading...
Loading...
News
all
press releases
TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up
Tandem Diabetes beats Q1 revenue and earnings estimates as gross margin expands, but shares decline 23.6% after the results announcement.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?
ABT's Q1 beat was overshadowed by Exact Sciences dilution, legal risks and weak Diagnostics trends as shares hit a 52-week low.
Zacks·2d ago
News Placeholder
Tandem Diabetes Care (TNDM) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Tandem Diabetes Care (TNDM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·3d ago
News Placeholder
Company News for May 8, 2026
Companies in The News Are: MCFT,TNDM,ZTS,BDX
Zacks·7d ago
News Placeholder
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +34.78% and +3.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·8d ago
News Placeholder
Tandem Diabetes Care Announces First Quarter 2026 Financial Results
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic...
Business Wire·8d ago
News Placeholder
Jennison Associates LLC Purchases 601,260 Shares of Tandem Diabetes Care, Inc. $TNDM
Jennison Associates LLC grew its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 42.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,021,376 shares of the medical device c...
MarketBeat·13d ago
News Placeholder
Tandem Diabetes Care (TNDM) Projected to Post Earnings on Thursday
Tandem Diabetes Care (NASDAQ:TNDM) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-tandem-diabetes-care-inc-stock...
MarketBeat·15d ago
News Placeholder
Tandem Diabetes Care Announces Upcoming Conference Presentations
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor...
Business Wire·16d ago
<
1
2
...
>

Latest TNDM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.